Lupin Ltd Quarterly Results
Q2 FY25-26 Results Summary
Revenue
The revenue stands at ₹7,047.51 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.43 per cent from ₹6,268.34 crore. This corresponds to a year-on-year *(YoY) growth of 24.23 per cent.
Operating Profit
Operating Profit stands at ₹197.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 15.69 per cent from ₹170.80 crore. This corresponds to a year-on-year *(YoY) growth of 74.61 per cent.
PBDT
PBDT stands at ₹838.91 crore, reflecting a quarter-on-quarter *(QoQ) increase of 70.14 per cent from ₹493.06 crore. This corresponds to a year-on-year *(YoY) growth of 85.48 per cent.
Profit Before Tax
Profit Before Tax stands at ₹2,006.97 crore, reflecting a quarter-on-quarter *(QoQ) increase of 41.78 per cent from ₹1,415.54 crore. This corresponds to a year-on-year *(YoY) growth of 90.26 per cent.
Net Profit
Net Profit stands at ₹1,477.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 21.24 per cent from ₹1,219.03 crore. This represents a 73.34 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Lupin Ltd News
Lupin Ltd Earnings
- YOY
- QOQ
Lupin Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Lupin Ltd Research Reports
Lupin Ltd Financial Reports
Lupin Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lupin | 1.03% | 0.34% | 1.61% | 9.29% | 14.47% | 9.88% |
| Torrent Pharma. | -0.47% | 2.06% | 2.70% | 6.07% | 11.76% | 32.38% |
| Cipla | 0.25% | 0.96% | -8.22% | -11.47% | -11.52% | -7.19% |
| Dr Reddy's Labs | 0.70% | 1.67% | 4.13% | 2.98% | 3.71% | 4.11% |
| Zydus Lifesci. | 0.68% | -1.34% | -0.22% | -6.12% | -6.60% | -4.41% |
| Mankind Pharma | 0.23% | -0.14% | -6.62% | -8.51% | -14.45% | -14.12% |
| Alkem Lab | 1.47% | 3.97% | 0.31% | 2.11% | 14.29% | 25.02% |
Company Info
Company Information
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Officer : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Director & Group CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Independent Director : Punita Lal